Late-breaking data from Abbott's groundbreaking first-in-human study demonstrated successful implantation of the company's AVEIR Conduction System Pacing (CSP) leadless pacemaker Enrollment has also begun in the ASCEND CSP pivotal clinical trial to evaluate Abbott's investigational CSP...
Read More Details
Finally We wish PressBee provided you with enough information of ( Abbott Highlights New AVEIR™ Data, Initiates Trial for the Company's Conduction System Pacing Technology )
Also on site :
- Mass shooting in Myrtle Beach tourist hotspot leaves 11 injured, suspect killed by police
- At Least 11 Dead After Driver Plowed Into Crowd at a Filipino Festival in Vancouver
- Fragile peace shattered: Kashmir attack pushes India, Pakistan to brink